rs768076848

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP6BS1

The NM_002109.6(HARS1):​c.679T>G​(p.Ser227Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,612,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00013 ( 0 hom., cov: 31)
Exomes š‘“: 0.000045 ( 0 hom. )

Consequence

HARS1
NM_002109.6 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 7.74
Variant links:
Genes affected
HARS1 (HGNC:4816): (histidyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a cytoplasmic enzyme which belongs to the class II family of aminoacyl-tRNA synthetases. The enzyme is responsible for the synthesis of histidyl-transfer RNA, which is essential for the incorporation of histidine into proteins. The gene is located in a head-to-head orientation with HARSL on chromosome five, where the homologous genes share a bidirectional promoter. The gene product is a frequent target of autoantibodies in the human autoimmune disease polymyositis/dermatomyositis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07897431).
BP6
Variant 5-140677705-A-C is Benign according to our data. Variant chr5-140677705-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 576600.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000133 (20/150604) while in subpopulation AMR AF= 0.00114 (17/14964). AF 95% confidence interval is 0.000723. There are 0 homozygotes in gnomad4. There are 14 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HARS1NM_002109.6 linkc.679T>G p.Ser227Ala missense_variant Exon 7 of 13 ENST00000504156.7 NP_002100.2 P12081-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HARS1ENST00000504156.7 linkc.679T>G p.Ser227Ala missense_variant Exon 7 of 13 1 NM_002109.6 ENSP00000425634.1 P12081-1

Frequencies

GnomAD3 genomes
AF:
0.000133
AC:
20
AN:
150486
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00114
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000443
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000131
AC:
33
AN:
251488
Hom.:
0
AF XY:
0.000103
AC XY:
14
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000452
AC:
66
AN:
1461546
Hom.:
0
Cov.:
30
AF XY:
0.0000440
AC XY:
32
AN XY:
727114
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000198
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.000133
AC:
20
AN:
150604
Hom.:
0
Cov.:
31
AF XY:
0.000191
AC XY:
14
AN XY:
73448
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00114
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000443
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000147
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000494
AC:
6
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Sep 17, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 26752306, 29235198) -

Apr 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The HARS1 c.679T>G; p.Ser227Ala variant has been reported once in a CMT patient who carried a second variant of the same gene (Lupo 2016). This variant is found in the Latino population with an allele frequency of 0.09% (31/35,428 alleles) in the Genome Aggregation Database (v2.1.1) and has been reported to the ClinVar database (ClinVar ID: 576600). Computational analyses predict that this variant is neutral (REVEL: 0.145). However, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. References: Lupo et al. Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy. J Mol Diagn. 2016 Mar;18(2):225-34. PMID: 26752306. -

not specified Benign:1
Oct 19, 2020
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Usher syndrome type 3B Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.19
.;T;T;T;T;.;.;T;T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.21
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.83
T;T;.;T;T;T;T;T;T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.079
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.39
.;.;N;N;.;.;.;.;.
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.26
N;N;.;N;N;N;N;N;N
REVEL
Benign
0.14
Sift
Uncertain
0.0020
D;D;.;D;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;.;D;D;D;D;D;.
Polyphen
0.099, 0.0040, 0.15
.;B;B;B;.;.;.;B;.
Vest4
0.26
MutPred
0.56
.;.;Gain of ubiquitination at K230 (P = 0.123);Gain of ubiquitination at K230 (P = 0.123);.;.;.;.;.;
MVP
0.69
MPC
0.36
ClinPred
0.19
T
GERP RS
3.2
Varity_R
0.66
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs768076848; hg19: chr5-140057290; API